CONSTELLIUM SE (CSTM)

FR0013467479 - Common Stock

10.48  -0.04 (-0.38%)

After market: 10.48 0 (0%)

Fundamental Rating

4

Taking everything into account, CSTM scores 4 out of 10 in our fundamental rating. CSTM was compared to 154 industry peers in the Metals & Mining industry. CSTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. CSTM scores decently on growth, while it is valued quite cheap. This could make an interesting combination.



5

1. Profitability

1.1 Basic Checks

CSTM had positive earnings in the past year.
In the past year CSTM had a positive cash flow from operations.
CSTM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CSTM had a positive operating cash flow.

1.2 Ratios

With a decent Return On Assets value of 2.08%, CSTM is doing good in the industry, outperforming 62.59% of the companies in the same industry.
CSTM's Return On Equity of 11.00% is fine compared to the rest of the industry. CSTM outperforms 78.23% of its industry peers.
CSTM has a Return On Invested Capital of 5.72%. This is in the better half of the industry: CSTM outperforms 67.35% of its industry peers.
CSTM had an Average Return On Invested Capital over the past 3 years of 7.53%. This is in line with the industry average of 8.79%.
Industry RankSector Rank
ROA 2.08%
ROE 11%
ROIC 5.72%
ROA(3y)4.78%
ROA(5y)3.05%
ROE(3y)49.93%
ROE(5y)N/A
ROIC(3y)7.53%
ROIC(5y)6.69%

1.3 Margins

With a Profit Margin value of 1.46%, CSTM perfoms like the industry average, outperforming 59.86% of the companies in the same industry.
In the last couple of years the Profit Margin of CSTM has declined.
With a Operating Margin value of 4.19%, CSTM perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
CSTM's Operating Margin has improved in the last couple of years.
The Gross Margin of CSTM (9.49%) is worse than 61.22% of its industry peers.
In the last couple of years the Gross Margin of CSTM has remained more or less at the same level.
Industry RankSector Rank
OM 4.19%
PM (TTM) 1.46%
GM 9.49%
OM growth 3Y4.37%
OM growth 5Y2.19%
PM growth 3YN/A
PM growth 5Y-12.18%
GM growth 3Y-0.76%
GM growth 5Y0.72%

2

2. Health

2.1 Basic Checks

CSTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CSTM has been increased compared to 1 year ago.
CSTM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CSTM has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.10 indicates that CSTM is not a great score, but indicates only limited risk for bankruptcy at the moment.
CSTM has a Altman-Z score (2.10) which is in line with its industry peers.
The Debt to FCF ratio of CSTM is 17.08, which is on the high side as it means it would take CSTM, 17.08 years of fcf income to pay off all of its debts.
CSTM has a Debt to FCF ratio (17.08) which is comparable to the rest of the industry.
CSTM has a Debt/Equity ratio of 1.97. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.97, CSTM is not doing good in the industry: 93.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF 17.08
Altman-Z 2.1
ROIC/WACC0.66
WACC8.65%

2.3 Liquidity

A Current Ratio of 1.28 indicates that CSTM should not have too much problems paying its short term obligations.
CSTM has a Current ratio of 1.28. This is amonst the worse of the industry: CSTM underperforms 82.31% of its industry peers.
CSTM has a Quick Ratio of 1.28. This is a bad value and indicates that CSTM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.52, CSTM is doing worse than 91.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.52

4

3. Growth

3.1 Past

CSTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
CSTM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.70% yearly.
Looking at the last year, CSTM shows a decrease in Revenue. The Revenue has decreased by -9.26% in the last year.
CSTM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.95% yearly.
EPS 1Y (TTM)-18.37%
EPS 3YN/A
EPS 5Y15.7%
EPS Q2Q%-67.44%
Revenue 1Y (TTM)-9.26%
Revenue growth 3Y14.02%
Revenue growth 5Y4.95%
Sales Q2Q%-4.71%

3.2 Future

The Earnings Per Share is expected to grow by 36.51% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.73% on average over the next years.
EPS Next Y-14.8%
EPS Next 2Y28.06%
EPS Next 3Y36.51%
EPS Next 5YN/A
Revenue Next Year-7.13%
Revenue Next 2Y-1.57%
Revenue Next 3Y5.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.78, CSTM is valued correctly.
CSTM's Price/Earnings ratio is rather cheap when compared to the industry. CSTM is cheaper than 80.27% of the companies in the same industry.
When comparing the Price/Earnings ratio of CSTM to the average of the S&P500 Index (27.40), we can say CSTM is valued rather cheaply.
The Price/Forward Earnings ratio is 7.30, which indicates a rather cheap valuation of CSTM.
CSTM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSTM is cheaper than 85.71% of the companies in the same industry.
CSTM is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.78
Fwd PE 7.3

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSTM is valued cheaper than 81.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CSTM is valued cheaper than 82.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.91
EV/EBITDA 5.51

4.3 Compensation for Growth

A more expensive valuation may be justified as CSTM's earnings are expected to grow with 36.51% in the coming years.
PEG (NY)N/A
PEG (5Y)0.81
EPS Next 2Y28.06%
EPS Next 3Y36.51%

0

5. Dividend

5.1 Amount

CSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONSTELLIUM SE

NYSE:CSTM (1/6/2025, 7:00:00 PM)

After market: 10.48 0 (0%)

10.48

-0.04 (-0.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-23 2024-10-23/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst Owners94.73%
Inst Owner Change0%
Ins Owners1.48%
Ins Owner ChangeN/A
Market Cap1.53B
Analysts81.82
Price Target18.77 (79.1%)
Short Float %1.84%
Short Ratio1.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.21%
Min EPS beat(2)-61.15%
Max EPS beat(2)10.73%
EPS beat(4)1
Avg EPS beat(4)-46.37%
Min EPS beat(4)-76.87%
Max EPS beat(4)10.73%
EPS beat(8)1
Avg EPS beat(8)-40.69%
EPS beat(12)3
Avg EPS beat(12)2.71%
EPS beat(16)7
Avg EPS beat(16)138.22%
Revenue beat(2)0
Avg Revenue beat(2)-8.28%
Min Revenue beat(2)-9.9%
Max Revenue beat(2)-6.66%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)5.74%
Revenue beat(8)2
Avg Revenue beat(8)-2.19%
Revenue beat(12)6
Avg Revenue beat(12)0.32%
Revenue beat(16)10
Avg Revenue beat(16)1.19%
PT rev (1m)0%
PT rev (3m)-21.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-76.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-55.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE 12.78
Fwd PE 7.3
P/S 0.22
P/FCF 13.91
P/OCF 3.13
P/B 1.65
P/tB 3.75
EV/EBITDA 5.51
EPS(TTM)0.82
EY7.82%
EPS(NY)1.44
Fwd EY13.7%
FCF(TTM)0.75
FCFY7.19%
OCF(TTM)3.35
OCFY31.98%
SpS47.72
BVpS6.34
TBVpS2.8
PEG (NY)N/A
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 11%
ROCE 8.7%
ROIC 5.72%
ROICexc 6%
ROICexgc 7.16%
OM 4.19%
PM (TTM) 1.46%
GM 9.49%
FCFM 1.58%
ROA(3y)4.78%
ROA(5y)3.05%
ROE(3y)49.93%
ROE(5y)N/A
ROIC(3y)7.53%
ROIC(5y)6.69%
ROICexc(3y)7.96%
ROICexc(5y)7.19%
ROICexgc(3y)9.64%
ROICexgc(5y)8.76%
ROCE(3y)11.43%
ROCE(5y)10.16%
ROICexcg growth 3Y11.83%
ROICexcg growth 5Y3.13%
ROICexc growth 3Y12.64%
ROICexc growth 5Y3.72%
OM growth 3Y4.37%
OM growth 5Y2.19%
PM growth 3YN/A
PM growth 5Y-12.18%
GM growth 3Y-0.76%
GM growth 5Y0.72%
F-Score5
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF 17.08
Debt/EBITDA 3.09
Cap/Depr 126.8%
Cap/Sales 5.44%
Interest Coverage 2.51
Cash Conversion 82.78%
Profit Quality 108.08%
Current Ratio 1.28
Quick Ratio 0.52
Altman-Z 2.1
F-Score5
WACC8.65%
ROIC/WACC0.66
Cap/Depr(3y)98.88%
Cap/Depr(5y)94.55%
Cap/Sales(3y)3.93%
Cap/Sales(5y)4.02%
Profit Quality(3y)80.88%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3YN/A
EPS 5Y15.7%
EPS Q2Q%-67.44%
EPS Next Y-14.8%
EPS Next 2Y28.06%
EPS Next 3Y36.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.26%
Revenue growth 3Y14.02%
Revenue growth 5Y4.95%
Sales Q2Q%-4.71%
Revenue Next Year-7.13%
Revenue Next 2Y-1.57%
Revenue Next 3Y5.73%
Revenue Next 5YN/A
EBIT growth 1Y-20.89%
EBIT growth 3Y19.01%
EBIT growth 5Y7.25%
EBIT Next Year52.02%
EBIT Next 3Y28.89%
EBIT Next 5YN/A
FCF growth 1Y-38.15%
FCF growth 3Y3.6%
FCF growth 5YN/A
OCF growth 1Y7.94%
OCF growth 3Y14.85%
OCF growth 5Y50.29%